Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national
national blog main
national top stories
new york blog main
san francisco blog main
sanofi
3
×
alnylam pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
abiraterone
ac immune
acorda therapeutics
activism
acute hepatic porphyria
aduro biotech
agenus
What
gene
3
×
bio
drug
roundup
therapy
advanced
alnylam’s
alzheimer’s
approval
aren’t
bff
car
companies
conference
cutting
deals
devoted
different
disease
easl
edge
experiments
fail
form
hot
increases
interference
kicked
latest
launch
liver
major
market
medicines
payers
pharmaceutical
photos
plan
prescription
price
Language
Current search:
sanofi
×
gene
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
